Maintaining pharmaceutical cGMP compliance requires more than preparing for a scheduled FDA inspection. It depends on effective quality systems, thorough documentation, established procedures, and consistent adherence to regulatory requirements. Identifying potential deficiencies before they become significant compliance issues is essential to protecting product quality, minimizing operational disruptions, and maintaining inspection readiness.
PD Partners provides pharmaceutical quality assurance consulting, quality system assessments, and mock FDA inspections to help companies evaluate their regulatory compliance and identify opportunities for improvement. Drawing on extensive industry and regulatory experience, our team evaluates existing practices, identifies potential weaknesses, and provides practical recommendations to strengthen quality systems and prepare for regulatory inspections.
How It Works
Our quality assurance assessments are tailored to each client’s operations, regulatory requirements, and inspection objectives. Whether preparing for an FDA pre-approval inspection or evaluating an established quality system, we focus on identifying areas of potential concern and assessing the effectiveness of existing controls.
Depending on the scope of the assessment, our evaluations may address:
- Quality Management Systems — Evaluate established procedures, responsibilities, and quality oversight.
- Documentation & Data Integrity — Assess recordkeeping practices, document controls, and the reliability of regulated data.
- Deviation Management & CAPA — Review investigation procedures and corrective and preventive action processes.
- Change Control & Validation — Evaluate systems governing operational changes, equipment qualification, and process validation.
- Regulatory Inspection Readiness — Assess facility practices, personnel preparedness, and supporting documentation against applicable FDA expectations.
For pre-approval inspections, particular attention is given to ensuring that manufacturing processes, analytical procedures, validation activities, and supporting records are consistent with the applicable regulatory submission.
Our Quality Assurance & Audit Process
1. Initial Assessment
Evaluate the client’s quality systems, regulatory requirements, and inspection objectives to establish the scope of the assessment.
2. Documentation Review
Examine relevant procedures, quality records, validation documentation, and established compliance practices.
3. Quality System Audit
Conduct a structured assessment of operational practices and quality systems to identify potential regulatory deficiencies.
4. Mock FDA Inspection
Simulate relevant aspects of an FDA inspection to evaluate preparedness, documentation practices, and personnel readiness.
5. Findings & Recommendations
Document identified concerns, assess their potential significance, and provide practical recommendations for corrective action.
6. Corrective Action & Readiness Support
Assist clients in prioritizing improvements and evaluating corrective actions to strengthen compliance and inspection preparedness.
Benefits of Working with PD Partners
- Experienced quality assurance and regulatory inspection support
- Early identification of potential cGMP compliance deficiencies
- Comprehensive quality system assessments and mock FDA inspections
- Practical recommendations for corrective actions and continuous improvement
- Improved documentation practices and inspection preparedness
- Reduced risk of costly regulatory delays and operational disruptions
Our Commitment to Quality
As a DEA registered, FDA inspected, and cGMP compliant laboratory, PD Partners understands the importance of maintaining effective quality systems and consistent regulatory compliance. Our firsthand experience operating within a regulated pharmaceutical environment provides valuable perspective when evaluating the challenges faced by other pharmaceutical organizations.
We approach each assessment with scientific integrity, objectivity, and attention to detail, helping clients identify meaningful improvements and establish quality practices that support long term regulatory compliance.